Process / pipelineTranslational Pharmacokinetics

Allometric Pharmacokinetic Scaling

Allometric scaling is a mathematical approach for predicting human pharmacokinetics from preclinical animal data using body weight relationships. Developed systematically by Mordenti and colleagues in the late 1980s, it enables rational first-in-human dose prediction without assuming species-specific metabolic differences.

MethodMind'de açSoonVideoSoon

Tam yöntemi oku

Members only

Sign in with a free account to read this section.

Sign in

Sources

  1. Mordenti, J., & Chappell, W. (1989). The use of allometric scaling in toxicokinetic studies. Fundamental and Applied Toxicology, 13(2), 335-346. DOI: 10.1016/0272-0590(89)90189-5
  2. Feng, M. R., Chiang, S. T., & Grammatoglou, G. (2011). Allometric scaling of blood clearance from preclinical species to humans. Journal of Pharmaceutical and Biomedical Analysis, 21(2), 195-205. DOI: 10.1016/S0731-7085(99)00139-7

Related methods

ScholarGateAllometric PK Scaling (Allometric Pharmacokinetic Scaling). Retrieved 2026-06-04 from https://scholargate.app/tr/pharmacology/allometric-pk-scaling